Such EMT CTCs, reported in a variety of cancers, are characterised by the loss of epithelial markers (such as EpCAM) and have been known to evade capture by classical EpCAM-based CTC isolation systems [34,35,36]. The gene discussed is EPCAM; the disease is cancer.